We are proud to release our 4th annual Environmental, Social & Governance Report. Learn more about our progress, growth opportunities in our countries of operation (U.S., India & Ireland) and how we are moving forward. https://lnkd.in/edeU2BJV
Amneal Pharmaceuticals
Pharmaceutical Manufacturing
Bridgewater, New Jersey 173,879 followers
We make healthy possible.
About us
Amneal (NASDAQ: AMRX) is rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Our family delivers for yours through a robust U.S. generics business, a growing branded business and deepening portfolios in injectables, biosimilars and select international markets. We’ve bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. And we invest substantially in our people through leadership development and employee well-being programs – all so we can deliver even more value. We are Amneal and We make healthy possible. Content is for informational purposes only and 3rd party content does not reflect Amneal’s opinions. Amneal has the right to remove comments that violate another’s copyright or intellectual property, mention an Amneal product, use profanity or are defamatory, promote and solicit for third-party sites, initiatives, or products, or are factually inaccurate or misleading or spam. Amneal recommends that you consult with your healthcare provider regarding personal health matters. To report a product complaint or adverse event related to an Amneal product, contact Drug Safety at 877-835-5472, option 3 or [email protected]. If you are currently experiencing a life-threatening event, please immediately contact 911.
- Website
-
http://www.amneal.com
External link for Amneal Pharmaceuticals
- Industry
- Pharmaceutical Manufacturing
- Company size
- 5,001-10,000 employees
- Headquarters
- Bridgewater, New Jersey
- Type
- Public Company
- Founded
- 2002
Locations
-
Primary
400 Crossing Boulevard
Bridgewater, New Jersey 08807, US
Employees at Amneal Pharmaceuticals
Updates
-
We announced U.S. FDA approval for our new presentation of potassium phosphates in 0.9% sodium chloride injection intravenous (IV) ready-to-use (RTU) bags. This sterile presentation reduces the compounding steps for clinicians typically required with administering the product. https://lnkd.in/dz6j_Jvv Thanks to the expertise and dedication of our global team, we continue to demonstrate our deep capabilities in developing impactful complex products. Adverse effects reported for the potassium phosphates injection IV bags include hyperkalemia, hyperphosphatemia, hypocalcemia and hypomagnesemia. For full prescribing information, see package insert: https://lnkd.in/dGE-rWES
-
-
We are building on our progress. https://lnkd.in/giE5s3Pb
-
-
Innovating more complex medicines is just one of the many ways we make healthy possible. #AmnealbytheNumbers *AvKARE sales of Amneal label products, royalty income and international revenues are included within Generics Non-OSD consistent with how the Company manages its portfolio.
-
-
We have a growing global presence! Learn more: https://lnkd.in/eY_4MgFS
-
-
We are delivering on our promises to be a leader in complex medicines and a trusted partner in oncology. https://lnkd.in/eb5NN7fU
-
-
Learn more about our growth story: Amneal.com *Amneal has three reportable business segments: 1) Generics (includes retail, injectables, biosimilars & international revenue), 2) Specialty and 3) AvKARE (includes distribution, government label and institutional revenue).
-
Similar pages
Browse jobs
Stock
AMRX
NASDAQ
20 minutes delay
$6.88
0.18 (2.687%)
- Open
- 6.68
- Low
- 6.59
- High
- 6.975
Data from Refinitiv
See more info on